Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Mozaffari · SciRah

Researcher profile · Semantic Scholar

F. Mozaffari

Share profile

F. Mozaffari — researcher profile on SciRah

h-index: 13
Works: 28
Citations: 702

Most-cited papers

T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
M. Palma, G. Gentilcore, K. Heimersson, F. Mozaffari +6 more
2016Haematologica153 citations Open access
Semantic Scholar
NK-cell and T-cell functions in patients with breast cancer: effects of surgery and adjuvant chemo- and radiotherapy
F. Mozaffari, C. Lindemalm, A. Choudhury, H. Granstam-Björneklett +8 more
2007British Journal of Cancer82 citations Open access
Semantic Scholar
Signalling molecules and cytokine production in T cells of multiple myeloma‐increased abnormalities with advancing stage
F. Mozaffari, L. Hansson, S. Kiaii, Xiu-Li Ju +4 more
2004British Journal of Haematology78 citations Open access
Semantic Scholar
Telomerase (GV1001) vaccination together with gemcitabine in advanced pancreatic cancer patients.
C. Staff, F. Mozaffari, J. Frödin, H. Mellstedt +1 more
2014International Journal of Oncology75 citations Open access
Semantic Scholar
A Phase I safety study of plasmid DNA immunization targeting carcinoembryonic antigen in colorectal cancer patients.
C. Staff, F. Mozaffari, B. K. Haller, B. Wahren +1 more
2011Vaccine58 citations
Semantic Scholar
First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells
M. Hojjat-Farsangi, A. H. Daneshmanesh, A. Khan, J. Shetye +16 more
2018Leukemia48 citations Open access
Semantic Scholar
Systemic immune effects of adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide and/or radiotherapy in breast cancer: a longitudinal study
F. Mozaffari, C. Lindemalm, A. Choudhury, H. Granstam-Björneklett +6 more
2008Cancer Immunology and Immunotherapy37 citations Open access
Semantic Scholar
T cells from indolent CLL patients prevent apoptosis of leukemic B cells in vitro and have altered gene expression profile
S. Kiaii, P. Kokhaei, F. Mozaffari, E. Rossmann +9 more
2012Cancer Immunology and Immunotherapy25 citations Open access
Semantic Scholar
Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia (B-CLL)
S. Kiaii, A. Choudhury, F. Mozaffari, E. Kimby +2 more
2005Medical Oncology25 citations
Semantic Scholar
Immune response, depression and fatigue in relation to support intervention in mammary cancer patients
C. Lindemalm, F. Mozaffari, A. Choudhury, H. Granstam-Björneklett +6 more
2007Supportive Care in Cancer20 citations
Semantic Scholar
Clinical and Immune Effects of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer
G. Ullenhag, F. Mozaffari, M. Broberg, H. Mellstedt +1 more
2017PLoS ONE18 citations Open access
Semantic Scholar
Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia
M. Hojjat-Farsangi, M. Jeddi-Tehrani, A. Daneshmanesh, F. Mozaffari +8 more
2015PLoS ONE15 citations Open access
Semantic Scholar
Lenalidomide as immune adjuvant to a dendritic cell vaccine in chronic lymphocytic leukemia patients
M. Palma, L. Hansson, T. Mulder, L. Adamson +9 more
2018European Journal of Haematology13 citations
Semantic Scholar
Overcoming immunosuppressive mechanisms.
K. Widén, F. Mozaffari, A. Choudhury, H. Mellstedt
2008Annals of Oncology13 citations Open access
Semantic Scholar
Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia: long-term effects of fludarabine and alemtuzumab treatment
S. Kiaii, A. Choudhury, F. Mozaffari, Reza Rezvany +3 more
2006Leukemia and Lymphoma13 citations
Semantic Scholar
Phase I–II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints
M. Winqvist, F. Mozaffari, M. Palma, Sandra Eketorp Sylvan +4 more
2016Cancer Immunology and Immunotherapy9 citations Open access
Semantic Scholar
Autologous T cells expressing the oncogenic transcription factor KLF6-SV1 prevent apoptosis of chronic lymphocytic leukemia cells
P. Kokhaei, M. Hojjat-Farsangi, F. Mozaffari, A. Moshfegh +6 more
2018PLoS ONE5 citations Open access
Semantic Scholar
Phase I study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukaemia: maintaining immune functions during therapy‐induced immunosuppression
S. E. Sylvan, E. Rossmann, F. Mozaffari, A. Porwit +5 more
2012British Journal of Haematology5 citations
Semantic Scholar
In Vivo Effects of Lenalidomide on T Cell Proliferation and Immune Checkpoint Molecules in Patients with Advanced Stage CLL: Results from a Phase II Study
M. Winqvist, F. Mozaffari, M. Palma, S. E. Sylvan +3 more
20153 citations
Semantic Scholar
Patients with Chronic Lymphocyte Leukemia (CLL) Have Naturally Occurring Antibodies Against the Receptor Tyrosine Kinase (ROR1)
M. Hojjat-Farsangi, F. Mozaffari, A. Daneshmanesh, A. Österborg +2 more
20113 citations
Semantic Scholar
DNA immunization targeting carcinoembryonic antigen in colorectal cancer patients
C. Staff, F. Mozaffari, K. Haller, P. Blomberg +4 more
20172 citations Open access
Semantic Scholar
Treatment of advanced pancreatic cancer patients with a telomerase-peptide vaccine together with gemcitabine: A phase II clinical study.
A. Choudhury, S. Mosolits, C. Staff, M. Liljefors +4 more
20072 citations
Semantic Scholar
First-in-Class Oral Small Molecule Against the Tyrosine Kinase ROR1 (KAN0439834) Induced Significant Apoptosis of Chronic Lymphocytic Leukemia Cells
M. Hojjat-Farsangi, A. Daneshmanesh, F. Mozaffari, L. Hansson +11 more
20171 citations
Semantic Scholar
36PImmunomodulatory effects of lenalidomide in combination with gemcitabine as first-line treatment in patients with advanced pancreatic cancer
M. Liljefors, F. Mozaffari, H. Mellstedt, G. Ullenhag
20150 citations Open access
Semantic Scholar
T Cells from Chronic Lymphocytic Leukemia (CLL) Patients Display Dysregulated Expression of Immune Checkpoint Molecules and Activation Markers Mainly Restricted to CD4+ Cells and Correlated with Disease Activity
M. Palma, G. Gentilcore, F. Mozaffari, K. Heimersson +4 more
20150 citations
Semantic Scholar
5.4 Phase-I-II Study of the Combination of Lenalidomide and Alemtuzumab in Patients with Advanced-Stage CLL
J. Lundin, S. E. Sylvan, E. Rossmann, F. Mozaffari +1 more
20110 citations
Semantic Scholar
T Cells from Patients with Chronic Lymphocytic Leukaemia Prevent Apoptosis of Autologous CLL Cells in a Dose- and Cell:Cell-Contact Dependent Fashion; Rationale for New Therapeutic Possibilities.
E. Rossmann, P. Kokhaei, F. Mozaffari, M. Palma +3 more
20080 citations
Semantic Scholar
T-Cell Function in Patients with B-Cell Chronic Lymphocytic Leukemia (B-CLL) Following Alemtuzumab (Campath®) or Fludarabine Treatment.
S. Kiaii, F. Mozaffari, J. Lundin, Reza Rezvany +3 more
20040 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Österborg×20
Invite
A. Österborg — researcher profile on SciRah
H. Mellstedt×16
Invite
H. Mellstedt — researcher profile on SciRah
L. Hansson×11
Invite
L. Hansson — researcher profile on SciRah
A. Choudhury×9
Invite
A. Choudhury — researcher profile on SciRah

×8

Invite

M. Palma — researcher profile on SciRah

H. Mellstedt×8

Invite

H. Mellstedt — researcher profile on SciRah

M. Liljefors×6

Invite

M. Liljefors — researcher profile on SciRah

M. Hojjat-Farsangi×6

Invite

M. Hojjat-Farsangi — researcher profile on SciRah

Invite

J. Lundin — researcher profile on SciRah

Invite

S. Kiaii — researcher profile on SciRah

Invite

E. Rossmann — researcher profile on SciRah

Invite

A. Moshfegh — researcher profile on SciRah